ArticleCureus2026
Primary Cutaneous Diffuse Large B-cell Lymphoma Presenting as a Non-healing Axillary Ulcer.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL) is a rare, aggressive lymphoma primarily affecting the skin. We report an unusual case of a female patient in her late 50s with a persistent non-healing ulcer in the left axilla, initially misdiagnosed as cutaneous tuberculosis. Despite empirical treatment, the ulcer worsened, leading to further investigation and a revised diagnosis of germinal centre-type PCDLBCL through biopsy and immunohistochemistry. The patient showed significant improvement in the wound following chemotherapy, but succumbed to complications of severe neutropenia and acute respiratory distress syndrome (ARDS). This case underscores the importance of early biopsy and histopathological evaluation in atypical, rapidly progressing cutaneous lesions to avoid misdiagnosis and ensure timely treatment, ultimately significantly improving patient outcomes in cases of primary cutaneous diffuse large B-cell lymphoma if managed and diagnosed early.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.